Pelisek J, Armeanu S, Nikol S
Medical Clinic I, Klinikum Grosshadern, Ludwig Maximilian University, Munich, Germany.
Cell Prolif. 2001 Oct;34(5):305-20. doi: 10.1046/j.0960-7722.2001.00215.x.
Smooth muscle cells and endothelial cells play an important role in cardiovascular diseases and may therefore be a potential target for gene therapy. Most in vitro experiments are performed using proliferating cell cultures. Nevertheless, non-dividing cells would represent more realistic in vivo conditions for gene therapy. Therefore, a simple method to achieve physiologically quiescence in cell cultures is needed for experiments. Growth to confluence is sufficient for endothelial cells to reach quiescence, in contrast to smooth muscle cells. Alternative techniques were investigated to achieve quiescence for smooth muscle cells. N-acetyl-cysteine, heparin, aphidicolin and serum-free medium are known inhibitors of smooth muscle cell proliferation and were tested for cell viability, necrosis and apoptosis. The inhibition status was evaluated counting cells in a cell counter. Toxicity, necrosis and apoptosis were determined using FACS analysis. Then, smooth muscle cells and endothelial cells were transfected with plasmid containing the beta-galactosidase gene using liposomes. Analysis of gene expression in transfected cells included a quantitative beta-galactosidase assay and X-gal staining. Growth inhibition was achieved with all agents tested. Using N-acetyl-cysteine, only slightly reduced growth rates were observed. Aphidicolin stopped cell growth almost immediately, but demonstrated enhanced toxicity. The amount of apoptotic and necrotic cells was lowest using heparin in the presence of foetal calf serum. Transfection experiments using stationary cultures of smooth muscle cells using heparin or aphidicolin demonstrated 5-10-fold lower transfection rates compared to transfected proliferating cell cultures serving as controls. Transfection experiments using stationary cultures of endothelial cells using growth inhibition through confluence demonstrated 40-fold lower transfection rates than transfected proliferating cell cultures. Transfer efficiency was much lower in endothelial cells compared to smooth muscle cells. In conclusion, quiescent cells simulate more realistically the in vivo situation and may therefore represent a better model for future in vivo experiments based on in vitro findings.
平滑肌细胞和内皮细胞在心血管疾病中发挥着重要作用,因此可能是基因治疗的潜在靶点。大多数体外实验是使用增殖细胞培养物进行的。然而,非分裂细胞对于基因治疗而言更能代表体内的实际情况。因此,实验需要一种在细胞培养中实现生理静止的简单方法。与平滑肌细胞不同,生长至汇合状态足以使内皮细胞达到静止。人们研究了其他技术来使平滑肌细胞达到静止。N-乙酰半胱氨酸、肝素、阿非迪霉素和无血清培养基是已知的平滑肌细胞增殖抑制剂,并对其细胞活力、坏死和凋亡情况进行了测试。通过细胞计数仪计数细胞来评估抑制状态。使用流式细胞术分析来确定毒性、坏死和凋亡情况。然后,使用脂质体将含有β-半乳糖苷酶基因的质粒转染到平滑肌细胞和内皮细胞中。对转染细胞中基因表达的分析包括定量β-半乳糖苷酶测定和X-gal染色。所有测试试剂均实现了生长抑制。使用N-乙酰半胱氨酸时,仅观察到生长速率略有降低。阿非迪霉素几乎立即停止了细胞生长,但显示出毒性增强。在胎牛血清存在的情况下,使用肝素时凋亡和坏死细胞的数量最少。与作为对照的转染增殖细胞培养物相比,使用肝素或阿非迪霉素对平滑肌细胞静止培养物进行的转染实验显示转染率低5至10倍。使用通过汇合实现生长抑制的内皮细胞静止培养物进行的转染实验显示,其转染率比转染增殖细胞培养物低40倍。与平滑肌细胞相比,内皮细胞的转染效率要低得多。总之,静止细胞更逼真地模拟了体内情况,因此可能是基于体外研究结果进行未来体内实验的更好模型。